New obesity drug combo tested in china – could it be a game-changer?
NCT ID NCT07017179
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 26 times
Summary
This study tests two experimental drugs, AZD6234 and AZD9550, alone or together, for weight loss in Chinese adults who are overweight or have obesity. About 871 participants aged 18 to 55 with a BMI of 27 or higher will receive the drugs or a placebo to check safety and effectiveness. The goal is to find a new treatment option for managing obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
ACTIVE_NOT_RECRUITINGJinan, 250001, China
-
Research Site
RECRUITINGNanjing, 210011, China
-
Research Site
RECRUITINGShanghai, 200032, China
Conditions
Explore the condition pages connected to this study.